Recent work from Fousteri Lab revealed a novel metabolic function of active transcription that is rapidly switched on globally in human cells to promote genetic accuracy, and reduce the mutation burden in genotoxins-exposed tissues, such as skin and lung, thus actively participating in lowering oncogenesis. Nat Com


On behalf of the Scientists and Personnel of BSRC Fleming I would like to express our sadness for the loss of Fotis Kafatos, an innovative mind that has influenced and shaped the development of Molecular Biology in Europe and in Greece. We extend our condolences to his family and the many students and colleagues he inspired through the years. 
George Kollias, President and Director of BSRC Fleming.



Recently published work from the Skoulakis lab suggests that cortical actin rearrangements underlie the little understood Anesthesia Resistant Memory, whose molecular mechanisms remained mysterious to date. Pubmed

Read more: 27/10/2017


The Genomics Facility of the BSRC Alexander Fleming, in collaboration with the lab of Iannis Talianidis, has developed a new high-throughput method for sequencing nascent RNAs labeled in vivo.

Read more: 27/07/2017


BSRC Fleming has signed a MoU with the National Bank of Greece sharing the common vision of fostering innovation and entrepreneurship in emerging areas of modern research. This partnership aims to contribute to the translation of scientific achievements into clinical practice and the development of innovative products of high added value. Press Release (in Greek).

Read more: 20/07/2017


Work by Fleming researchers has revealed that omic profiles of synovial fibroblasts from the Tg197 human TNF-transgenic model of arthritis greatly mimic human synovial fibroblast profiles from Rheumatoid arthritis patients, revealing commonly represented pathways that may constitute potential targets for future therapies (Pubmed, Editorial)

Read more: 12/05/2017


Fleming researchers have identified two new dual inhibitors of TNF and RANKL, two key factors involved in inflammatory processes. These inhibitors can be further optimized to develop improved treatments for a range of inflammatory, autoimmune, and bone loss diseases (PubMed, Ηighlights in international press).

Read more: 12/05/2017


Following a Forward Genetics approach, Fleming researchers identified a novel neurological mouse model caused by a functional mutation in the Slc25a46 gene, a new pathogenic target in a wide spectrum of human neurological diseases, including optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia. Pubmed

Read more: 20/04/2017


Expanding previous work on the role of autotaxin in chronic inflammatory disorders that have led to phase II clinical trials in idiopathic pulmonary fibrosis, Fleming researchers have now uncovered a novel, major role for this secreted lysophospholipase D in the pathogenesis of hepatitis and hepatocellular carcinoma. PubMed.

Read more: 19/12/2016


Fleming Researcher Dr Antigone Dimas has been awarded an ERC Starting Grant to explore the complex biological impact of dietary intake in humans. This is the fourth ERC grant awarded to a Fleming Researcher in the past 5 years. The title of Dr Dimas's grant is "A genomics and systems biology approach to explore the molecular signature and functional consequences of long-term, structured fasting in humans”. 

Read more: 20/09/2016


Recent work by Fleming researchers identifies a Wnt-regulated long non-coding RNA that controls intestinal stem cell fate and carcinogenesis. Pubmed

Read more: 16/06/2016


Recent work by Fleming researchers uncovered a protein methylation-dependent control mechanism in the pathogenesis of pulmonary fibrosis. Pubmed

Read more: 16/06/2016


Τhe 2011 Nobel Laureate in Physiology or Medicine, Prof. Bruce Beutler, will be visiting Fleming, on Tuesday May 24th, 2016, and at 12 noon, he will be discussing his life in science in an "Ask the Nobelist" Q&A session targeted to young scientists (open to the public). Prof. Beutler will also be giving inaugural addresses at the Academy of Athens on May 23rd, 2016 at 20:00 and the University of Athens on May 24th, 2016 at 19:00.

Read more: 28/04/2016


Recent work by Fleming researchers demonstrates that the histone methyltransferase Smyd3 is required for the development of experimentally induced liver and colon cancer in mice. Pubmed

Read more: 01/03/2016


The study by Fleming researchers highlighted in December 2015 (Koliaraki et al., J. Exp. Med. 2015) is featured in a “News & Views” article in Nature. The commentary highlights the possible fundamentally different and even opposing functions of intestinal fibroblast subpopulations in regulating inflammation and tumour formation and underscores the need to further characterize these cells to reveal new mechanisms underlying pathogenesis of chronic inflammation and cancer.


B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us